<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Atossa Genetics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven C. Quay, MD, PhD
    • FOUNDED
      2009
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    American International Holdings Corp.

    American International Holdings Corp.

    American International Industries, Inc. (OTCQB: AMIN) is a diversified holding com...

    American International Industries, Inc. (OTCQB:...

    Filing Type:    RA
    Veracyte, Inc.

    Veracyte, Inc.

    Veracyte is a leading genomic diagnostics company that is fundamentally improving ...

    Veracyte is a leading genomic diagnostics compa...

    Filing Type:    PU
    Sabra Health Care REIT, Inc.

    Sabra Health Care REIT, Inc.

    As of June 30, 2019, Sabra’s investment portfolio included 432 real estate prope...

    As of June 30, 2019, Sabra’s investment portf...

    Filing Type:    PU
    Conatus Pharmaceuticals Inc.

    Conatus Pharmaceuticals Inc.

    Conatus Pharmaceuticals is a biotechnology company focused on the development and ...

    Conatus Pharmaceuticals is a biotechnology comp...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    Oncolytics Biotech Inc.

    Oncolytics Biotech Inc.

    Oncolytics is focused on obtaining regulatory approval for pelareorep for metastat...

    Oncolytics is focused on obtaining regulatory a...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.